Filing Details
- Accession Number:
- 0001209191-14-056122
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-05 16:05:14
- Reporting Period:
- 2014-09-03
- Filing Date:
- 2014-09-05
- Accepted Time:
- 2014-09-05 16:05:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113148 | Infinity Pharmaceuticals Inc. | INFI | Pharmaceutical Preparations (2834) | 330655706 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1492805 | J. Vito Palombella | C/O Infinity Pharmaceuticals, Inc. 780 Memorial Drive Cambridge MA 02139 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-09-03 | 7,105 | $2.04 | 7,105 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-09-03 | 2,367 | $2.04 | 9,472 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-09-03 | 9,472 | $15.39 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-03 | 7,105 | $0.00 | 7,105 | $2.04 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-09-03 | 2,367 | $0.00 | 2,367 | $2.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-05-10 | 2015-05-10 | No | 4 | M | Direct |
0 | 2005-05-10 | 2015-05-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,388 | Indirect | By 401k |
Footnotes
- The acquisition and disposition reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2013.
- The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2013.
- This stock option was granted under the issuer's Pre-Merger Stock Incentive Plan, which permits the early exercise of unvested stock options in exchange for shares of restricted stock that are subject to a right of repurchase by the issuer that lapses in accordance with the vesting schedule of the original option. This option is fully vested.